BlackRock »

Monopar Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2025-09-30 $17M 204k 81.67
2025-06-30 $7.3M 205k 35.78
2025-03-31 $527k 15k 36.41
2024-12-31 $178k 8.1k 22.00